Company Details
| Sector | PHARMACEUTICALS |
| Address | One IBL Centre 2nd Floor Plot # 1 Block 7 & 8 D.M.C.H.S Tipu Sultan Road Off Shahrah-e-Faisal Karachi |
| Auditor | A. F. Ferguson & Co. Chartered Accountants |
| Registrar | CDC Share Registrar Services Limited, CDC House, 99-B , Block B S.M.C.H.S Main Shahrah-e-Faisal, Karachi |
| Website | www.searlecompany.com |
| Fiscal Year | June |
| Details |
Details
The Searle Company Limited was incorporated in Pakistan as a private limited company in October 1965. In November 1993@ the Company was converted into a public limited company under the repealed Companies Ordinance@ 1984 (now Companies Act@ 2017). The Company is principally engaged in the manufacture of pharmaceutical and other consumer products. International Brands (Private) Limited is the Parent Company@ which holds 56.32% shareholding in the Company.
Company Announcements
| Date/Time | Announcement |
|---|---|
| 25/05/2023 15:46:56 | RIGHT ISSUE = 31.13 AT A PREMIUM OF Rs.25/= PER SHARE FOR THE YEAR ENDED 2023 |
| 28/04/2023 16:35:28 | FINANCIAL RESULT FOR THE NINE MONTHS ENDED 31/03/2023 (CONSOLIDATED) PROFIT/LOSS AFTER TAXATION RS. IN MILLION 943.477 (CONSOLIDATED) PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,538.388 EPS = 2.14 |
| 28/04/2023 16:33:52 | (UNCONSOLIDATED) PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 778.426 (UNCONSOLIDATED) PROFIT/LOSS AFTER TAXATION RS. IN MILLION 639.421 EPS = 1.64 FINANCIAL RESULT FOR THE NINE MONTHS ENDED 31/03/2023 |
| 02/03/2023 16:09:50 | FINANCIAL RESULT FOR THE HALF YEAR ENDED 31/12/2022 (CONSOLIDATED) PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,157.510 (CONSOLIDATED) PROFIT/LOSS AFTER TAXATION RS. IN MILLION 706.152 EPS = 1.61 |
| 02/03/2023 16:09:23 | EPS = 1.39 FINANCIAL RESULT FOR THE HALF YEAR ENDED 31/12/2022 (UNCONSOLIDATED) PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 614.961 (UNCONSOLIDATED) PROFIT/LOSS AFTER TAXATION RS. IN MILLION 542.385 |